Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.93

-4.2%

2:08 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (453)	12/21/1999 10:26:00 PM
From: Larry Liebman	Read Replies (1) of 52153

Looking at biotechs left at the altar. Have been tempted by BCHE. However, my experience with bio-frustration issues like ISIP and LGND, have led me away from issues that are perennial wallflowers. On the other hand, BCHE is profitable and....I continue to hold out great expectation for BTRN, which appears to have a role in the appreciation of MEDI, and truly is a micro-cap. Likewise, VRTX will probably ascend on some take-out rumors. Any other ideas I should be doing some DD over? P.S. I continue to look over at AXPH. I just have a lack of confidence in management regarding the manner in which they squandered SQNA!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next